Understanding Ciprofloxacin Failure in Pseudomonas aeruginosa Biofilm: Persister Cells Survive Matrix Disruption

Biofilms are commonly recalcitrant to antibiotics, through incompletely elucidated mechanisms such as tolerance and persistence. We aimed at investigating how a Pseudomonas aeruginosa biofilm escapes ciprofloxacin treatment. P. aeruginosa PA14 in vitro mature biofilms were challenged with supra-MIC ciprofloxacin concentrations. Cell viability was quantified by fluorescein diacetate assay. Population dynamics were determined by counts of surviving culturable cells. Biofilms were analyzed using confocal laser scanning microscopy (CLSM), and the expression of genes involved in stringent response, toxin-antitoxin HigB/HigA, and type 3 secretion system (T3SS) was quantified by RT-qPCR in untreated and treated biofilms. Ciprofloxacin exposure resulted in an initial reduction of bacterial counts following a biphasic time-kill curve. After 24 h of treatment, the overall cell activity and the density of culturable cells significantly decreased as compared to untreated biofilm. No resistant mutant was isolated among the <1% surviving cells. Phenotypic adaptation toward persistence appeared to start after only 1 h of antibiotic exposure, by an overexpression of the genes involved in stringent response and in the toxin-antitoxin system, whereas the expression of genes encoding for the T3SS remained unchanged. After 4 h of ciprofloxacin exposure, stringent response genes returned to their basal level of expression. After a prolonged ciprofloxacin exposure, a deep alteration in the matrix structure that became thinner and lost mushroom-like aggregates was observed, in relation with reduced biovolumes of exopolysaccharides and extracellular DNA. These results support that ciprofloxacin might first induce the bacterial killing of most bacterial cells, but simultaneously activate stringent response mechanisms contributing to the switch of a subpopulation toward a persister phenotype. Once the persister phenotype is expressed, and despite an unexpected alteration of the biofilm matrix, ciprofloxacin fails to eradicate biofilm.

[1]  S. Ni,et al.  Antitoxin HigA inhibits virulence gene mvfR expression in Pseudomonas aeruginosa. , 2019, Environmental microbiology.

[2]  T. Tolker-Nielsen,et al.  Tolerance and Resistance of Pseudomonas aeruginosa Biofilms to Antimicrobial Agents—How P. aeruginosa Can Escape Antibiotics , 2019, Front. Microbiol..

[3]  K. Alzoubi,et al.  In Vitro Comparison of Antibacterial and Antibiofilm Activities of Selected Fluoroquinolones against Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus , 2019, Pathogens.

[4]  K. Kishi,et al.  Sub-minimum inhibitory concentrations of ceftazidime inhibit Pseudomonas aeruginosa biofilm formation. , 2018, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[5]  K. Gerdes,et al.  Retraction Notice to: (p)ppGpp Controls Bacterial Persistence by Stochastic Induction of Toxin-Antitoxin Activity , 2018, Cell.

[6]  A. Oliver,et al.  Antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa: Guidelines by the Spanish Society of Chemotherapy , 2018, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

[7]  B. Rehm,et al.  Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence , 2017, Front. Cell. Infect. Microbiol..

[8]  K. Gerdes,et al.  Mechanisms of bacterial persistence during stress and antibiotic exposure , 2016, Science.

[9]  M. Hussain,et al.  ANTIMICROBIAL SUSCEPTIBILITY , 2016, The Professional Medical Journal.

[10]  A. Jahns,et al.  Transcriptomic analysis of Propionibacterium acnes biofilms in vitro. , 2016, Anaerobe.

[11]  Y. Liu,et al.  HigB of Pseudomonas aeruginosa Enhances Killing of Phagocytes by Up-Regulating the Type III Secretion System in Ciprofloxacin Induced Persister Cells , 2016, Front. Cell. Infect. Microbiol..

[12]  J. Sutton,et al.  Evaluation of antibiotic efficacy against infections caused by planktonic or biofilm cultures of Pseudomonas aeruginosa and Klebsiella pneumoniae in Galleria mellonella. , 2015, International journal of antimicrobial agents.

[13]  Boo Shan Tseng,et al.  Pel is a cationic exopolysaccharide that cross-links extracellular DNA in the Pseudomonas aeruginosa biofilm matrix , 2015, Proceedings of the National Academy of Sciences.

[14]  Z. Aktaş,et al.  Antimicrobial Activity of Fosfomycin-Tobramycin Combination against Pseudomonas aeruginosa Isolates Assessed by Time-Kill Assays and Mutant Prevention Concentrations , 2015, Antimicrobial Agents and Chemotherapy.

[15]  M. Rohde,et al.  In Vivo Efficacy of Antimicrobials against Biofilm-Producing Pseudomonas aeruginosa , 2015, Antimicrobial Agents and Chemotherapy.

[16]  A. Oliver,et al.  ESCMID guideline for the diagnosis and treatment of biofilm infections 2014. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[17]  James P. Folsom,et al.  Contribution of Stress Responses to Antibiotic Tolerance in Pseudomonas aeruginosa Biofilms , 2015, Antimicrobial Agents and Chemotherapy.

[18]  M. Maciá,et al.  Antimicrobial susceptibility testing in biofilm-growing bacteria. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[19]  David Lebeaux,et al.  Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics , 2014, Microbiology and Molecular Reviews.

[20]  K. Lewis,et al.  Pseudomonas aeruginosa Biofilms in Disease , 2014, Microbial Ecology.

[21]  R. Hancock,et al.  A Broad-Spectrum Antibiofilm Peptide Enhances Antibiotic Action against Bacterial Biofilms , 2014, Antimicrobial Agents and Chemotherapy.

[22]  Diarmaid Hughes,et al.  Microbiological effects of sublethal levels of antibiotics , 2014, Nature Reviews Microbiology.

[23]  Mohammad Wahid Ansari,et al.  The legal status of in vitro embryos , 2014 .

[24]  D. Lebeaux,et al.  From in vitro to in vivo Models of Bacterial Biofilm-Related Infections , 2013, Pathogens.

[25]  Stephanie M. Amato,et al.  The role of metabolism in bacterial persistence , 2013, Front. Microbiol..

[26]  F. Lépine,et al.  Active Starvation Responses Mediate Antibiotic Tolerance in Biofilms and Nutrient-Limited Bacteria , 2011, Science.

[27]  G. Wong,et al.  The Pel Polysaccharide Can Serve a Structural and Protective Role in the Biofilm Matrix of Pseudomonas aeruginosa , 2011, PLoS pathogens.

[28]  S. Lory,et al.  Emergence of Pseudomonas aeruginosa Strains Producing High Levels of Persister Cells in Patients with Cystic Fibrosis , 2010, Journal of bacteriology.

[29]  A. Hauser,et al.  Pseudomonas aeruginosa Cytotoxin ExoU Is Injected into Phagocytic Cells during Acute Pneumonia , 2010, Infection and Immunity.

[30]  T. Tolker-Nielsen,et al.  Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB‐oprM genes , 2008, Molecular microbiology.

[31]  J. Martínez,et al.  Antibiotics as signals that trigger specific bacterial responses. , 2008, Current opinion in microbiology.

[32]  H. Nelis,et al.  Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates. , 2008, Journal of microbiological methods.

[33]  S. Chevalier,et al.  Outer membrane modifications of Pseudomonas fluorescens MF37 in response to hyperosmolarity. , 2008, Journal of Proteome Research.

[34]  K. Hirota,et al.  Functional Analysis of spoT, relA and dksA Genes on Quinolone Tolerance in Pseudomonas aeruginosa under Nongrowing Condition , 2006, Microbiology and immunology.

[35]  S. Leibler,et al.  Bacterial Persistence as a Phenotypic Switch , 2004, Science.

[36]  K. Drlica The mutant selection window and antimicrobial resistance. , 2003, The Journal of antimicrobial chemotherapy.

[37]  Philip S. Stewart,et al.  Contributions of Antibiotic Penetration, Oxygen Limitation, and Low Metabolic Activity to Tolerance of Pseudomonas aeruginosa Biofilms to Ciprofloxacin and Tobramycin , 2003, Antimicrobial Agents and Chemotherapy.

[38]  K. Lewis,et al.  Biofilms and Planktonic Cells of Pseudomonas aeruginosa Have Similar Resistance to Killing by Antimicrobials , 2001, Journal of bacteriology.

[39]  R. Donlan Biofilm formation: a clinically relevant microbiological process. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  B. Ersbøll,et al.  Quantification of biofilm structures by the novel computer program COMSTAT. , 2000, Microbiology.

[41]  P. Stewart,et al.  Role of Antibiotic Penetration Limitation in Klebsiella pneumoniae Biofilm Resistance to Ampicillin and Ciprofloxacin , 2000, Antimicrobial Agents and Chemotherapy.

[42]  J. Costerton,et al.  Bacterial biofilms: a common cause of persistent infections. , 1999, Science.

[43]  D. Veal,et al.  Rapid screening of the antimicrobial activity of extracts and natural products. , 1994, The Journal of antibiotics.

[44]  T. Yokota,et al.  Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin , 1993, Antimicrobial Agents and Chemotherapy.

[45]  T. Elliott,et al.  The response of Escherichia coli to ciprofloxacin and norfloxacin. , 1987, Journal of medical microbiology.

[46]  R. Cantón,et al.  Elección del tratamiento antibiótico en la infección invasiva aguda por Pseudomonas aeruginosa: guía de la Sociedad Española de Quimioterapia , 2018 .

[47]  C. J. Jones,et al.  Bacterial Extracellular Polysaccharides in Biofilm Formation and Function , 2015, Microbiology spectrum.

[48]  K. Lewis,et al.  Persister cells. , 2010, Annual review of microbiology.

[49]  R. Hancock,et al.  Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances , 2008, Nature Protocols.

[50]  Andrew B. Mahon,et al.  Optimisation of the fluorescein diacetate antibacterial assay. , 2005, Journal of microbiological methods.

[51]  G. O’Toole,et al.  Mechanisms of biofilm resistance to antimicrobial agents. , 2001, Trends in microbiology.

[52]  J. Bryers Bacterial biofilms. , 1993, Current opinion in biotechnology.

[53]  Chunfang ZHANGt Pseudomonas aeruginosa. , 1966, Lancet.